Gadoterate meglumine
DGD-44-057
Approved small_molecule terminated
Quick answer
Gadoterate meglumine for Hepatocellular Carcinoma is a Approved program (small_molecule) at Guerbet with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Guerbet
- Indication
- Hepatocellular Carcinoma
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated